Information about IOP
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0743.457.092

VAT liability
Yes
Established
10-02-2020
Last balance sheet year
2024
Company size
Micro 0 FTE
Full name
Immuno-Oncology Partners
Principal activity
Business and other management consultancy activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from IOP

2024 2023 2022 2021
Profit/Loss € 17,728 -64 % € 49,085 -69 % € 158,251 64 % € 96,557
Equity € 326,620 6 % € 308,892 19 % € 259,708 156 % € 101,458
Gross margin € 34,599 -55 % € 77,247 -64 % € 215,983 59 % € 135,910

Publications from IOP

Date Publication
12-08-2024 Registered Office (FR)
12-02-2020 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Immuno-Oncology Partners?
The VAT number of Immuno-Oncology Partners is BE 0743.457.092.
Wat is the PEPPOL ID of Immuno-Oncology Partners?
There is no information available about the PEPPOL ID of Immuno-Oncology Partners or the company is not yet registered on the PEPPOL network.
When was Immuno-Oncology Partners founded?
Immuno-Oncology Partners was founded on 10-02-2020.
What is the address of Immuno-Oncology Partners?
The current registered office of Immuno-Oncology Partners is located at Avenue de Tervueren 402, 1150 Woluwe-Saint-Pierre.
When was the last time Immuno-Oncology Partners filed their annual financial statements?
The most recent financial statements of Immuno-Oncology Partners were filed on 03-04-2025.
How many employees does Immuno-Oncology Partners have?
There are currently no employees working at Immuno-Oncology Partners or no workforce information is available.
What is the annual turnover of Immuno-Oncology Partners?
At the time of its most recent financial statements, Immuno-Oncology Partners did not publish any turnover figures. Immuno-Oncology Partners reported a gross margin of €34,599.02.

Sources